[Coenzyme q10 in complex therapy of patients with ischemic heart disease]

Kardiologiia. 2013;53(8):40-3.
[Article in Russian]

Abstract

The paper contains results of assessment of clinical efficacy and safety of coenzyme Q10 in patients with ischemic heart disease. Coenzyme Q10 (60 mg/day for 8 weeks) added to basic treatment of patients with stable class II-III angina significantly improved clinical status of these patients without clinically significant side effects.

Publication types

  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Angina, Stable / drug therapy*
  • Angina, Stable / metabolism
  • Angina, Stable / physiopathology
  • Angina, Stable / psychology
  • Behavioral Symptoms / drug therapy*
  • Blood Glucose
  • Cardiovascular Agents / administration & dosage
  • Cardiovascular Agents / adverse effects
  • Drug Monitoring
  • Exercise Tolerance / drug effects
  • Female
  • Humans
  • Lipid Metabolism / drug effects*
  • Male
  • Middle Aged
  • Quality of Life
  • Severity of Illness Index
  • Symptom Assessment
  • Treatment Outcome
  • Ubiquinone / administration & dosage
  • Ubiquinone / adverse effects
  • Ubiquinone / analogs & derivatives*
  • Vitamins / administration & dosage
  • Vitamins / adverse effects

Substances

  • Blood Glucose
  • Cardiovascular Agents
  • Vitamins
  • Ubiquinone
  • coenzyme Q10